Venova Medical Inc. is a clinical-stage medical device company headquartered in Los Gatos, California. Founded in 2018, the firm focuses on addressing challenges associated with providing optimal vascular access for patients requiring hemodialysis. The privately held company develops specialized vascular technologies to improve patient care outcomes.
Subscribe to see Venova Medical Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Venova Medical Inc is a medical devices company headquartered in United States. Its most recent funding round raised $9.7M in August 2024. Xcout tracks 7 named people at Venova Medical Inc, including Erik van der Burg (Co-Founder, Director & CEO).
1 more named person on record for Venova Medical Inc, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $9.7M | — | |
| Series B | $30M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Venova Medical Inc's closest competitors — see the full list of competitors and alternatives →
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Innova Vascular, Inc. is a medical device company based in Irvine, California, engaged in the development of innovative minimally invasive vascular technologies such as the Laguna Thrombectomy System.
PuraCath Medical, Inc. is a medical device company focused on vascular access solutions. Headquartered in Newark, California, the company develops specialized technologies to improve safety and outcomes for patients requiring vascular access.
Quanta Dialysis Technologies is a medical-device company that develops hemodialysis systems, notably its compact SC+ platform. Its products are intended for use by dialysis providers and healthcare professionals in clinical and home-care settings to treat patients with kidney failure.
Phraxis Inc. is a medical device company based in Minneapolis, Minnesota, dedicated to redefining outcomes in vascular access for hemodialysis patients. The company specializes in endovascular technologies such as its EndoForce device.
Cardiva Medical, Inc. is a privately held medical device manufacturer headquartered in Santa Clara, California, specializing in vascular closure and related healthcare products.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.